Apr 03 2018
Robotics Business Review
The recent FDA clearance for Auris Health, formerly known as Auris Surgical Robotics, brings to light the immense opportunity for the surgical robotics market as it continues to grow. According to the article, the competition is growing, and the global surgical robotics market could reach $12.6 billion by 2025. The article also highlights the importance of collaboration between the robotics companies and hospitals to allow for full adoption of surgical robots.
Excerpts from the article: "The market for surgical robots continues to show massive growth as companies invest more money and resources into creating platforms that can help doctors more efficiently and accurately perform procedures."
"Smith said the emergence of new companies in the short term could reduce costs and stimulate competition among robot companies, especially those that compete for the same procedures."Read the Full Article about Auris Here
Complications from bronchoscopy are rare and most often minor, but if they occur, may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. Only rarely do patients experience other more serious complications (for example, collapsed lung, respiratory failure, heart attack and/or cardiac arrhythmia).
Adverse effects from both Mini-PCNL and Ureteroscopy include pain, urinary tract infection, fever, hematuria (presence of blood in urine), exposure to low levels of radiation, retained or residual stones.
Adverse effects from ureteroscopy may include pain, perforation or injury to the ureter, resulting in extravasation of fluid and urine (urinoma), stricture of the ureter with risk of subsequent obstruction (hydronephrosis needing further repair), rare avulsion of the ureter, urinary blood clots, residual stones.
PCNL access may result in minor and major adverse effects. Minor effects include fever and nephrostomy leak. Major adverse effects may include injuries to pleura, liver, spleen, large vessels with related bleeding, gallbladder, duodenum, jejunum, colon with related cutaneous fistula, fever, pain, ileus, elevated counts.
Major adverse effects related to stone removal may include infection and urosepsis, intravascular fluid overload, extravasation of fluid, and post percutaneous nephrolithotomy bleeding.